CoChat
Sign Up
Cited by 54

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients

Niino, Masaaki, Kikuchi, Seiji, Fukazawa, Toshiyuki, Yabe, Ichiro, Tashiro, Kunio·2003·Journal of Neuroimmunology
DOI 10.1016/s0165-5728(03)00004-3
Open this paper in CoChat — free account

Abstract

Osteopontin (OPN) exhibits pleiotropic functions and abundant transcripts for OPN are present in brains of patients with multiple sclerosis (MS). The aim of this study was to investigate the role of OPN genes in the pathogenesis of MS. Polymorphisms at the 8090th, 9250th and 9583rd positions in OPN were detected by PCR-RFLP from DNAs of 116 MS Japanese patients and 124 healthy controls. The C/C genotype at the 8090th position in exon 6 was more prevalent in MS than in control (p<0.0001), and C allele was more prevalent in MS than in control (p<0.0001, OR=2.57, 95% CI=1.65-4.00). For the 9583rd position polymorphism in exon 7, patients with G/G genotype (age; 32.1+/-12.5 years, mean+/-S.D.) showed a later disease onset than G/A (age; 25.9+/-7.8 years, p=0.01) and A/A (age; 25.2+/-8.9 years, p=0.01) genotypes. There were no significant correlations between OPN gene polymorphisms and disease progression. Our results suggest that the 8090th polymorphism might be associated with susceptibility to MS, while the 9583rd polymorphism might be associated with age of onset of MS.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0165-5728(03)00004-3

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 33

  1. Almasy, 2002, Association studies of vascular phenotypes: how and why?, Arterioscler., Thromb., Vasc. Biol., 22, 1055, 10.1161/01.ATV.0000024686.49995.41 · DOI
  2. Ashkar, 2000, Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity, Science, 287, 860, 10.1126/science.287.5454.860 · DOI
  3. Denhardt, 1993, Osteopontin: a protein with diverse functions, FASEB J., 7, 1475, 10.1096/fasebj.7.15.8262332 · DOI
  4. Ebers, 1996, A full genome search in multiple sclerosis, Nat. Genet., 13, 472, 10.1038/ng0896-472 · DOI
  5. Fisher, 2001, Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin, Biochem. Biophys. Res. Commun., 280, 460, 10.1006/bbrc.2000.4146 · DOI
  6. Forton, 2002, An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus, Hum. Mutat., 19, 459, 10.1002/humu.9025 · DOI
  7. Fukazawa, 1992, MRI findings of multiple sclerosis with acute transverse myelopathy, J. Neurol. Sci., 110, 27, 10.1016/0022-510X(92)90005-6 · DOI
  8. Haines, 1996, A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group, Nat. Genet., 13, 469, 10.1038/ng0896-469 · DOI
  9. Iwasaki, 2001, Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals, J. Hum. Genet., 46, 544, 10.1007/s100380170037 · DOI
  10. Kantarci, 2002, Identifying disease modifying genes in multiple sclerosis, J. Neuroimmunol., 123, 144, 10.1016/S0165-5728(01)00481-7 · DOI
  11. Katagiri, 1995, Functional analysis of the osteopontin molecule, Ann. N. Y. Acad. Sci., 760, 371, 10.1111/j.1749-6632.1995.tb44660.x · DOI
  12. Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 · DOI · Paper page
  13. McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann. Neurol., 50, 121, 10.1002/ana.1032 · DOI · Paper page
  14. Niino, 2000, Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles, J. Neurol. Sci., 177, 65, 10.1016/S0022-510X(00)00336-1 · DOI
  15. Niino, 2000, Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis, J. Neurol. Sci., 179, 70, 10.1016/S0022-510X(00)00381-6 · DOI
  16. Niino, 2001, Genetic polymorphisms of IL-1beta and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients, J. Neuroimmunol., 118, 295, 10.1016/S0165-5728(01)00339-3 · DOI
  17. Niino, 2001, Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis, Tissue Antigens, 58, 93, 10.1034/j.1399-0039.2001.580205.x · DOI
  18. Niino, 2002, An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis. B.M.C., Neurology, 2, 8
  19. Niino, 2002, No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS, J. Neuroimmunol., 127, 177, 10.1016/S0165-5728(02)00099-1 · DOI
  20. Okinaka, 1966, The prevalence of multiple sclerosis and other neurological diseases in Japan, Acta Neurol. Scand., 42, 68
  21. Oksenberg, 2001, Multiple sclerosis: genomic rewards, J. Neuroimmunol., 113, 171, 10.1016/S0165-5728(00)00444-6 · DOI
  22. Oldberg, 1986, Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg–Gly–Asp cell-binding sequence, Proc. Natl. Acad. Sci. U. S. A., 83, 8819, 10.1073/pnas.83.23.8819 · DOI
  23. O'Regan, 2000, Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks, Immunol. Today, 21, 475, 10.1016/S0167-5699(00)01715-1 · DOI
  24. Patarca, 1990, Dysregulated expression of the T cell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease, J. Exp. Med., 172, 1177, 10.1084/jem.172.4.1177 · DOI
  25. Reinholt, 1990, Osteopontin—a possible anchor of osteoclasts to bone, Proc. Natl. Acad. Sci. U. S. A., 87, 4473, 10.1073/pnas.87.12.4473 · DOI
  26. Rittling, 1999, Osteopontin function in pathology: lessons from osteopontin-deficient mice, Exp. Nephrol., 7, 103, 10.1159/000020591 · DOI
  27. Rollo, 1996, Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages, J. Leukocyte Biol., 60, 397, 10.1002/jlb.60.3.397 · DOI
  28. Sawcer, 1996, A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22, Nat. Genet., 13, 464, 10.1038/ng0896-464 · DOI
  29. Singh, 1990, Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo, J. Exp. Med., 171, 1931, 10.1084/jem.171.6.1931 · DOI
  30. Weinshenker, 1995, The natural history of multiple sclerosis, Neurol. Clin., 13, 119, 10.1016/S0733-8619(18)30064-1 · DOI
  31. Young, 1990, cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN), Genomics, 7, 491, 10.1016/0888-7543(90)90191-V · DOI
  32. Yu, 1989, Multiple sclerosis amongst Chinese in Hong Kong, Brain, 112, 1445, 10.1093/brain/112.6.1445 · DOI
  33. Yu, 1998, A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat, Proc. Assoc. Am. Physicians, 110, 50

Cited by

Sorted by citations

See all 54

Metadata

Authors
Niino, M., Kikuchi, S., Fukazawa, T., Yabe, I., & Tashiro, K.
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2003-03
Volume
136
Issue
1-2
Pages
125-129
ISSN
0165-5728
DOI
10.1016/s0165-5728(03)00004-3
Cited by
54
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review